Current guidelines recommend use of one or more long-acting inhaled bronchodilators for patients with moderate, severe, or very severe COPD. However, the initial choice of long-acting inhaled ...

Bronchodilator therapy forms the mainstay of treatment for people with COPD. Bronchodilators work by altering the airways’ smooth muscle tone, leading to widening of the airways, which ...

COPD exacerbations are likely to be an important phenotype for pharmacogenetics studies. - The role of ADRB2 variants as pharmacogenetic determinants of response to short-acting bronchodilators ...

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage to the airways. It typically refers to emphysema and chronic bronchitis.

The drug has a marketing authorisation in a pressurised metered-dose inhaler (pMDI), as a maintenance dual bronchodilator to relieve symptoms in adults with COPD. Bevespi, which is taken twice ...

support the published findings of other recent COPD studies in which the beneficial ... even when other bronchodilators are unavailable or unaffordable (7). History and outlook Following its ...

Individuals with impaired lung function trajectories experience a higher burden of respiratory symptoms, including wheeze and ...

COPD can be managed by proper medications like bronchodilators, oxygen therapy, breathing exercises, quitting smoking and a good diet. Acute exacerbations of COPD cases (AECOPD) need medical ...

China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...